Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Hypermarcas Total Liabilities 2010-2025 | HYPMY

Hypermarcas total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
  
Hypermarcas Annual Total Liabilities
(Millions of US $)
2024 $2,310
2023 $2,602
2022 $2,538
2021 $1,850
2020 $1,554
2019 $813
2018 $626
2017 $749
2016 $767
2015 $2,379
2014 $2,740
2013 $2,528
2012 $2,980
2011 $4,014
2010 $2,814
2009 $1,448
Hypermarcas Quarterly Total Liabilities
(Millions of US $)
2025-03-31 $2,149
2024-12-31 $2,310
2024-09-30 $2,462
2024-06-30 $2,557
2024-03-31 $2,736
2023-12-31 $2,602
2023-09-30 $2,636
2023-06-30 $2,576
2023-03-31 $2,252
2022-12-31 $2,538
2022-09-30 $2,299
2022-06-30 $2,175
2022-03-31 $2,005
2021-12-31 $1,850
2021-09-30 $1,984
2021-06-30 $1,692
2021-03-31 $1,577
2020-12-31 $1,554
2020-09-30 $1,447
2020-06-30 $1,228
2020-03-31 $749
2019-12-31 $813
2019-09-30 $555
2019-06-30 $502
2019-03-31 $505
2018-12-31 $626
2018-09-30 $527
2018-06-30 $507
2018-03-31 $546
2017-12-31 $749
2017-09-30 $599
2017-06-30 $820
2017-03-31 $674
2016-12-31 $767
2016-09-30 $1,055
2016-06-30 $1,130
2016-03-31 $1,099
2015-12-31 $2,379
2015-09-30 $2,029
2015-06-30 $2,322
2015-03-31 $2,181
2014-12-31 $2,740
2014-09-30 $2,732
2014-06-30 $2,618
2014-03-31 $2,410
2013-12-31 $2,528
2013-09-30 $2,751
2013-06-30 $2,857
2013-03-31 $2,848
2012-12-31 $2,980
2012-09-30 $3,050
2012-06-30 $3,359
2012-03-31 $3,601
2011-12-31 $4,014
2011-09-30 $4,315
2011-06-30 $4,354
2011-03-31 $3,784
2010-12-31 $2,814
2010-09-30 $2,241
2010-06-30 $1,811
2010-03-31 $1,624
2009-12-31 $1,448
2009-09-30 $890
2009-06-30 $722
2009-03-31 $698
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.958B $1.380B
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $84.152B 31.57
Zoetis (ZTS) United States $75.067B 28.01
Takeda Pharmaceutical (TAK) Japan $47.697B 9.49
Daiichi Sankyo, - (DSNKY) Japan $46.849B 23.83
Sandoz Group AG (SDZNY) Switzerland $23.527B 0.00
Merck (MKKGY) Germany $17.005B 12.46
Summit Therapeutics (SMMT) United States $14.653B 0.00
United Therapeutics (UTHR) United States $14.421B 12.76
Shionogi (SGIOY) Japan $14.275B 14.30
Neurocrine Biosciences (NBIX) United States $12.332B 42.24
Orion OYJ (ORINY) Finland $10.083B 27.27
IPSEN (IPSEY) France $10.039B 0.00
Corcept Therapeutics (CORT) United States $7.318B 59.49
Stevanato Group S.p.A (STVN) Italy $7.038B 43.04
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.086B 0.00
Grifols, S.A (GRFS) Spain $5.995B 0.00
Ionis Pharmaceuticals (IONS) United States $5.609B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.791B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.093B 10.84
Crinetics Pharmaceuticals (CRNX) United States $3.026B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.298B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.247B 12.15
NewAmsterdam Pharma (NAMS) Netherlands $2.190B 0.00
Indivior (INDV) United States $1.874B 7.95
Recursion Pharmaceuticals (RXRX) United States $1.858B 0.00
Dyne Therapeutics (DYN) United States $1.590B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.584B 0.00
Evotec AG (EVO) Germany $1.424B 0.00
Ocular Therapeutix (OCUL) United States $1.348B 0.00
Guardian Pharmacy Services (GRDN) United States $1.324B 0.00
ARS Pharmaceuticals (SPRY) United States $1.320B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.093B 21.86
Harrow (HROW) United States $1.054B 0.00
Enliven Therapeutics (ELVN) United States $1.049B 0.00
Akebia Therapeutics (AKBA) United States $0.969B 0.00
Collegium Pharmaceutical (COLL) United States $0.948B 5.11
Avadel Pharmaceuticals (AVDL) Ireland $0.913B 0.00
Ardelyx (ARDX) United States $0.871B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xeris Biopharma Holdings (XERS) United States $0.697B 0.00
KalVista Pharmaceuticals (KALV) United States $0.686B 0.00
Xencor (XNCR) United States $0.649B 0.00
Liminatus Pharma (LIMN) United States $0.640B 0.00
AleAnna (ANNA) United States $0.608B 0.00
Elite Pharmaceuticals (ELTP) United States $0.595B 0.00
Regulus Therapeutics (RGLS) United States $0.561B 0.00
Relay Therapeutics (RLAY) United States $0.555B 0.00
USANA Health Sciences (USNA) United States $0.541B 11.77
Theravance Biopharma (TBPH) United States $0.539B 0.00
Bioventus (BVS) United States $0.535B 13.56
Verve Therapeutics (VERV) United States $0.511B 0.00
Tourmaline Bio (TRML) United States $0.485B 0.00
Zevra Therapeutics (ZVRA) United States $0.483B 0.00
Oruka Therapeutics (ORKA) United States $0.456B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.450B 0.00
Altimmune (ALT) United States $0.443B 0.00
Siga Technologies (SIGA) United States $0.420B 8.78
Savara (SVRA) United States $0.411B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.375B 10.13
Organogenesis (ORGO) United States $0.365B 0.00
Aquestive Therapeutics (AQST) United States $0.355B 0.00
Heron Therapeutics (HRTX) United States $0.305B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.281B 0.00
Nature's Sunshine Products (NATR) United States $0.267B 24.68
MediWound (MDWD) Israel $0.234B 0.00
ProKidney (PROK) United States $0.230B 0.00
Esperion Therapeutics (ESPR) United States $0.230B 0.00
Nanobiotix S.A (NBTX) France $0.216B 0.00
4D Molecular Therapeutics (FDMT) United States $0.181B 0.00
Journey Medical (DERM) United States $0.176B 0.00
Profound Medical (PROF) Canada $0.170B 0.00
Lyell Immunopharma (LYEL) United States $0.170B 0.00
Aclaris Therapeutics (ACRS) United States $0.169B 0.00
OmniAb (OABI) United States $0.169B 0.00
Larimar Therapeutics (LRMR) United States $0.158B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.154B 0.00
Avita Medical (RCEL) United States $0.152B 0.00
Aldeyra Therapeutics (ALDX) United States $0.147B 0.00
Inhibikase Therapeutics (IKT) United States $0.146B 0.00
Nektar Therapeutics (NKTR) United States $0.126B 0.00
Wellgistics Health (WGRX) United States $0.125B 0.00
Achieve Life Sciences (ACHV) Canada $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Korro Bio (KRRO) United States $0.116B 0.00
Cardiol Therapeutics (CRDL) Canada $0.114B 0.00
Lexeo Therapeutics (LXEO) United States $0.109B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.108B 0.00
Cassava Sciences (SAVA) United States $0.102B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Fractyl Health (GUTS) United States $0.095B 0.00
Inotiv (NOTV) United States $0.093B 0.00
Unicycive Therapeutics (UNCY) United States $0.093B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.092B 0.00
VAXART, INC (VXRT) United States $0.090B 0.00
Champions Oncology (CSBR) United States $0.090B 14.77
Arch Biopartners (ACHFF) Canada $0.088B 0.00
Galectin Therapeutics (GALT) United States $0.082B 0.00
Nutriband (NTRB) United States $0.081B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.081B 60.00
Pyxis Oncology (PYXS) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Surrozen (SRZN) United States $0.074B 0.00
Dominari Holdings (DOMH) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.062B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Telomir Pharmaceuticals (TELO) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.056B 0.00
Prelude Therapeutics (PRLD) United States $0.055B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
NRx Pharmaceuticals (NRXP) United States $0.051B 0.00
Context Therapeutics (CNTX) United States $0.049B 0.00
PMV Pharmaceuticals (PMVP) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Avalo Therapeutics (AVTX) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
Rafael Holdings (RFL) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
Karyopharm Therapeutics (KPTI) United States $0.037B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
Lyra Therapeutics (LYRA) United States $0.034B 0.00
PolyPid (PYPD) Israel $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Tempest Therapeutics (TPST) United States $0.029B 0.00
Jupiter Neurosciences (JUNS) United States $0.027B 0.00
Relmada Therapeutics (RLMD) United States $0.027B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
DURECT (DRRX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Ainos (AIMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
GlycoMimetics (GLYC) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.18
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
SHINECO (SISI) China $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Incannex Healthcare (IXHL) Australia $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00